Cargando…
Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma
Despite advances and introduction of new therapies in the last decade, metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis. The development of androgen axis-targeted therapies such as abiraterone acetate, enzalutamide and darolutamide can prolong survival in mCPRC; however,...
Autores principales: | Seale, Katelyn Nazaneen, Labriola, Matthew K, Jiang, Xiaoyin "Sara", Armstrong, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535143/ https://www.ncbi.nlm.nih.gov/pubmed/36198431 http://dx.doi.org/10.1136/bcr-2022-251036 |
Ejemplares similares
-
Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis
por: Lia, Massimiliano, et al.
Publicado: (2022) -
Severe thoracic pyomyositis in a patient with systemic lupus erythematosus
por: Kuo, Yu-Ning, et al.
Publicado: (2022) -
A case of successful pregnancy managed in a patient living with Motor Neurone Disease for more than 3 years
por: Ali, Abdisamad, et al.
Publicado: (2022) -
Total neurological recovery after surgical decompression and treatment with denosumab of large unresectable spinal giant cell tumour expanding to mediastinum
por: Anusitviwat, Chirathit, et al.
Publicado: (2022) -
Non-arteritic anterior ischaemic optic neuropathy (NA-AION) and COVID-19 vaccination
por: Sanjay, Srinivasan, et al.
Publicado: (2022)